Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C6H12O5 |
| Molecular Weight | 164.1565 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(OC[C@H](O)[C@H]1O)[C@H](O)CO
InChI
InChIKey=JNYAEWCLZODPBN-JGWLITMVSA-N
InChI=1S/C6H12O5/c7-1-3(8)6-5(10)4(9)2-11-6/h3-10H,1-2H2/t3-,4+,5-,6-/m1/s1
1,4-Sorbitan is a sorbitol anhydration product. 1,4-Sorbitan is a precursor to environmentally benign surfactants. It is a component of Sorbitol-Sorbitan mixtures used as soft gel plasticizers. They enhance the soft gelatin capsule finish gloss for a premium appearance, help to prevent leakage, provide consistent pharmaceutical quality, and extend shelf life by maintaining a proper moisture balance within the capsule shell.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. | 2005 Mar-Apr |
|
| Formulation and evaluation of a vitamin C multiple emulsion. | 2006 |
|
| Optimization of lipase-catalyzed synthesis of sorbitan acrylate using response surface methodology. | 2007 Apr |
|
| Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation. | 2007 Jan 2 |
|
| The use of solvent relaxation technique to investigate headgroup hydration and protein binding of simple and mixed phosphatidylcholine/surfactant bilayer membranes. | 2007 May |
|
| Some considerations about the hydrophilic-lipophilic balance system. | 2008 May 22 |
|
| Efficacy of niosomal formulation of diallyl sulfide against experimental candidiasis in Swiss albino mice. | 2009 Oct |
|
| Between the devil and the deep blue sea: dispersants in the gulf of Mexico. | 2010 Aug |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C83486
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C83509
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | |||
|
27299-12-3
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | |||
|
AV0YTZ4E6J
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | |||
|
DTXSID50893383
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | |||
|
248-391-9
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | |||
|
10953859
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | |||
|
AV0YTZ4E6J
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | |||
|
1307571
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000087532
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | |||
|
1616008
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY | |||
|
SUB21060
Created by
admin on Fri Dec 15 16:06:18 GMT 2023 , Edited by admin on Fri Dec 15 16:06:18 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
